Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe: M.Sc. Lea Zemmrich

M.Sc. Lea Zemmrich

Ferdinand-Sauerbruch-Straße, 17475 Greifswald, Forschungslabor Frauenklinik DZ 7, Raum J-05.13

Since 2024: PhD student, Research Laboratory at the Department of Obstetrics and Gynecology, University Medicine Greifswald
- Focus: Reproductive Immunology, Decidual Stromal Cells
- Topic: The relevance of the uterine microbiome and immune system for early pregnancy events
2021-2023: Master of Science in Integrated Immunology, Friedrich-Alexander University Erlangen-Nuremberg
- Focus: Immunology, Virology, Cancer Immunology
- Thesis: CAR T cell marker expression in the context of radiotherapy
2018-2021: Bachelor of Science in Human Biology, University Greifswald
- Focus: Immunology, Biochemistry, Cell Biology, Forensic Pathology
- Thesis: Regulatory effect of Fusobacterium nucleatum on M2c macrophages

Topics: Reproductive immunology, angiogenesis, uterine microbiome
Methods: flow cytometry, RT-PCR, (fluorescence-) microscopy, ELISA, In-Cell Western

Since 12/2024: PhD-supporting scholarship from German Economy Foundation (Stiftung der Deutschen Wirtschaft)
11/2024: PhD-supporting scholarship via State Graduate Funding (Landesgraduiertenförderung)
2022: DAAD PROMOS scholarship and travel grand by Friedrich-Alexander University Erlangen-Nuremberg for research visit at Nepean Hospital, Sydney, Australia

2022: President’s Presenter’s Award for “Commensal F. nucleatum Bacterium Regulates the Expression of Pro-angiogenic Factors in vitro via PAR-1 Pathway” (L. Zemmrich, D. Muzzio, N. Normann, M. Zygmunt.), Denver, Colorado, Issued to Dr. Muzzio at the annual meeting of the Society for Reproductive Investigation (SRI)

P. Krupa, H. Wein, L. Zemmrich, D. Muzzio, M. Zygmunt. “Pregnancy-Related Factors Induce Immune Tolerance Through Regulation of sCD83 Release” in Frontiers in Immunology, 12.09.2024.
L. Zemmrich, D. Muzzio, N. Normann, M. Zygmunt. “Commensal F. nucleatum Bacterium Regulates the Expression of Pro-angiogenic Factors in vitro via PAR-1 Pathway”. Presented by Dr. Muzzio at the annual meeting of the Society for Reproductive Investigation (SRI), Denver, 2022